✦ LIBER ✦

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment

✍ Scribed by Masaru Jida; Shinichi Toyooka; Tetsuya Mitsudomi; Toshimi Takano; Keitaro Matsuo; Katsuyuki Hotta; Kazunori Tsukuda; Takafumi Kubo; Hiromasa Yamamoto; Masaomi Yamane; Takahiro Oto; Yoshifumi Sano; Katsuyuki Kiura; Yasushi Yatabe; Yuichiro Ohe; Hiroshi Date; Shinichiro Miyoshi

Book ID: 108586465
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 490 KB
Volume: 100
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01273.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A diagnostic algorithm using EGFR mutati

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

✍ Kawahara, Akihiko; Taira, Tomoki; Azuma, Koichi; Tominaga, Masaki; Hattori, Sato 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 641 KB

The EGFR mutation and its correlation wi

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer

✍ Zhang, X.-T. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 301 KB

Response to Treatment and Survival of Pa

Response to Treatment and Survival of Patients with Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing

✍ Sequist, L. V.; Joshi, V. A.; Janne, P. A.; Muzikansky, A.; Fidias, P.; Meyerson 📂 Article 📅 2007 🏛 Alphamed Press 🌐 English ⚖ 105 KB

Combination of EGFR gene copy number and

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

✍ Hirsch, F.; Varella-Garcia, M; Cappuzzo, F; McCoy, J; Bemis, L; Xavier, A.; Dzia 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 127 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Phase II prospective study of the effica

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy

✍ Sunaga, Noriaki; Tomizawa, Yoshio; Yanagitani, Noriko; Iijima, Hironobu; Kaira, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 177 KB